Incretins such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) could be involved in mechanisms compensating the increase in blood glucose due to insulin resistance observed in pregnant women [5]. The gene discussed is GCG; the disease is Insulin resistance.